Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: An adaptive multicentre, randomised, open-label, phase 3, superiority trial
Bekaii-Saab, T., Okusaka, T., Goldstein, D., Oh, D. -., Ueno, M., Ioka, T., Tabernero, J., . . . Van Cutsem, … Read More